Lixte Biotechnology Holdings, Inc.
Price Action
Technical Summary
WEAKENINGLixte Biotechnology Holdings, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 46), showing significant lag compared to the market leaders. Earnings growth of 25% provides fundamental context to the price action. However, price is extended 39% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.51 | +25.37% | ABOVE |
| 50 SMA | $3.16 | +39.31% | ABOVE |
| 100 SMA | $3.34 | +31.59% | ABOVE |
| 150 SMA | $3.70 | +19.03% | ABOVE |
| 200 SMA | $3.90 | +12.80% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LIXT in an uptrend right now?
LIXT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is LIXT overbought or oversold?
LIXT's RSI (14) is 70. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is LIXT outperforming the market?
LIXT has a Relative Strength (RS) Rating of 46 out of 99. LIXT is currently lagging the broader market.
Where is LIXT in its 52-week range?
LIXT is trading at $4.40, which is 70% of its 52-week high ($6.26) and 67% above its 52-week low ($0.64).
How volatile is LIXT?
LIXT has a Beta of 1.09 and 52-week volatility of 143%. It's more volatile than the S&P 500 - expect bigger swings.